Channels

 

Special Offers & Promotions

 

 

Latest News

 

 

View Channel

New Products

 

 

View Channel

Video Presentations

 

 

View Channel

Separation Science

 

 

View Channel

Microscopy & Image Analysis

 

 

View Channel

Laboratory Automation & IT Solutions

 

 

View Channel

 

Will BRIC be the Savior for the Life Sciences and Medical Devices Sector?

publication date: May 2, 2013
 | 
author/source: Frost & Sullivan

Frost and Sullivan

Discover key lessons from the field and best practices vital to reap rewards from these countries during Frost & Sullivan’s complimentary webinar

WHEN:                11:00 a.m. EDT on Wednesday, May 15, 2013
LOCATION:         Online, with free registration
MODERATOR     Frost & Sullivan Partner Reenita Das
SPEAKERS

  • Latin America Healthcare Leader Eduardo Golisano
  • South Asia and Middle EastHealthcare Director Sandeep Sinha
  • China Healthcare Director Xuchao Glenn Hou
  • Advanced Medical Technologies Global Program Manager Siddharth Saha


Multinational firms have been exploring opportunities in emerging markets as a strategy to face the Western slowdown. However, after facing limited growth in these regions during 2012, the major drug and device manufacturers are obliged to reassess their strategies.  Heavyweights of the drug business, including Pfizer Inc., Merck, Bristol-Myers Squibb, GlaxoSmithKline and Novartis, are discovering that conquering markets in countries such as Brazil, Russia, India and China is not as easy as originally assumed.

Attend this webinar to discover:

  • Insight from BRIC healthcare leaders as they share field experiences and best practices gathered through hundreds of successful cases
  • Common obstacles international companies must overcome in these regions
  • How to exploit the hidden potential of BRIC countries
  • Tactics to adjust strategy to successfully penetrate BRIC markets
  • The top 10 technologies and products expected to drive growth in these regions


The briefing will benefit any senior manager in the corporate strategy or global marketing areas that focuses on emerging markets, as well as any healthcare company looking to explore BRIC countries.

Supporting Quote

“Our team of more than 40 healthcare analysts on the ground in these four countries amassed an array of best practices of what works and what does not, based on actual experiences working through the regionally-specific barriers and opportunities alike,” said Frost & Sullivan Partner Reenita Das, who will moderate this webinar.  “These best practices provide excellent lessons learned in the trenches through hands-on experience, which will be very beneficial for any company currently in these markets or looking to enter in the future.  Our analysts have blazed the path to come out on the other side each time, more knowledgeable of the most opportune passageway.”

Supporting Resources

more information about Frost & Sullivan’s Healthcare practice

Registration

To attend the briefing, email anna.zanchi@frost.com your full name, job title, company name, company telephone number, company email address and website, city, state and country.

Receive a recorded version of the briefing anytime by submitting the aforementioned contact details.


 



 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month

Top 10 most popular articles this month

 

 

Today's Picks

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners

 

Exhibitions & Events